Atlas Trials

A Prospective Study on the Treatment of Recurrent/Refractory/Intolerable NSAA With Lusutrombopag

Clinical trial NCT06426043 · UNKNOWN

Trial details

NCT number
NCT06426043
Sponsor
Peking Union Medical College Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Aplastic Anemia
Start date
2024-06-01
Primary completion
2025-06-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.